Syngeneic N1-S1 Orthotopic Hepatocellular Carcinoma in Sprague Dawley Rat for the Development of Interventional Oncology-Based Immunotherapy: Survival Assay and Tumor Immune Microenvironment

Syngeneic N1-S1 Orthotopic Hepatocellular Carcinoma in Sprague Dawley Rat for the Development of Interventional Oncology-Based Immunotherapy: Survival Assay and Tumor Immune Microenvironment

Rodent HCC rat models provide advantages for interventional oncology (IO) based immunotherapy research compared to other established larger animal models or mice models. Rapid and predictable tumor growth and affordable costs permit the formation of a compelling preclinical model investigating novel...

Full description

Bibliographic Details
Main Authors: Bongseo Choi, Jason Pe, Bo Yu, Dong-Hyun Kim
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Cancers
Subjects:
hepatocellular carcinoma (HCC)
rodent HCC animal model
cancer immunotherapy
interventional oncology
Online Access:https://www.mdpi.com/2072-6694/15/3/913

Internet

https://www.mdpi.com/2072-6694/15/3/913

Similar Items